- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Non-steroidal Anti-inflammatory Drugs (NSAID) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Non-steroidal Anti-inflammatory Drugs (NSAID) market. Detailed analysis of key players, along with key growth strategies adopted by Non-steroidal Anti-inflammatory Drugs (NSAID) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Generic
Bayer
Merial
Zoetis
Elanco
St Joseph
Boehringer Ingelheim
Ecotrin
Merck Animal Health
By Type:
Salicylates
Propionic acid derivatives
Acetic acid derivatives
Enolic acid (Oxicam) derivatives
Anthranilic acid derivatives (Fenamates)
Selective COX-2 inhibitors (Coxibs)
Sulfonanilides
By End-User:
Human
Animals
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Non-steroidal Anti-inflammatory Drugs (NSAID) Market
-
1.3 Market Segment by Type
-
1.3.1 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Salicylates from 2016 to 2027
-
1.3.2 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Propionic acid derivatives from 2016 to 2027
-
1.3.3 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Acetic acid derivatives from 2016 to 2027
-
1.3.4 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Enolic acid (Oxicam) derivatives from 2016 to 2027
-
1.3.5 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Anthranilic acid derivatives (Fenamates) from 2016 to 2027
-
1.3.6 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Selective COX-2 inhibitors (Coxibs) from 2016 to 2027
-
1.3.7 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Sulfonanilides from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Human from 2016 to 2027
-
1.4.2 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Animals from 2016 to 2027
-
1.4.3 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Non-steroidal Anti-inflammatory Drugs (NSAID) Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Non-steroidal Anti-inflammatory Drugs (NSAID) by Major Types
-
3.4.1 Market Size and Growth Rate of Salicylates
-
3.4.2 Market Size and Growth Rate of Propionic acid derivatives
-
3.4.3 Market Size and Growth Rate of Acetic acid derivatives
-
3.4.4 Market Size and Growth Rate of Enolic acid (Oxicam) derivatives
-
3.4.5 Market Size and Growth Rate of Anthranilic acid derivatives (Fenamates)
-
3.4.6 Market Size and Growth Rate of Selective COX-2 inhibitors (Coxibs)
-
3.4.7 Market Size and Growth Rate of Sulfonanilides
4 Segmentation of Non-steroidal Anti-inflammatory Drugs (NSAID) Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Non-steroidal Anti-inflammatory Drugs (NSAID) by Major End-Users
-
4.4.1 Market Size and Growth Rate of Non-steroidal Anti-inflammatory Drugs (NSAID) in Human
-
4.4.2 Market Size and Growth Rate of Non-steroidal Anti-inflammatory Drugs (NSAID) in Animals
-
4.4.3 Market Size and Growth Rate of Non-steroidal Anti-inflammatory Drugs (NSAID) in Others
5 Market Analysis by Regions
-
5.1 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Production Analysis by Regions
-
5.2 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Landscape Analysis
-
6.1 West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Landscape Analysis by Major Types
-
6.2 West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Landscape Analysis by Major End-Users
7 South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Landscape Analysis
-
7.1 South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Landscape Analysis by Major Types
-
7.2 South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Landscape Analysis by Major End-Users
8 Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Landscape Analysis
-
8.1 Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Landscape Analysis by Major Types
-
8.2 Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Landscape Analysis by Major End-Users
9 Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Landscape Analysis
-
9.1 Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Landscape Analysis by Major Types
-
9.2 Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Generic
-
10.1.1 Generic Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Bayer
-
10.2.1 Bayer Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Merial
-
10.3.1 Merial Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Zoetis
-
10.4.1 Zoetis Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Elanco
-
10.5.1 Elanco Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 St Joseph
-
10.6.1 St Joseph Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Boehringer Ingelheim
-
10.7.1 Boehringer Ingelheim Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Ecotrin
-
10.8.1 Ecotrin Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Merck Animal Health
-
10.9.1 Merck Animal Health Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Salicylates from 2016 to 2027
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Propionic acid derivatives from 2016 to 2027
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Acetic acid derivatives from 2016 to 2027
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Enolic acid (Oxicam) derivatives from 2016 to 2027
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Anthranilic acid derivatives (Fenamates) from 2016 to 2027
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Selective COX-2 inhibitors (Coxibs) from 2016 to 2027
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Sulfonanilides from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Human from 2016 to 2027
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Animals from 2016 to 2027
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Non-steroidal Anti-inflammatory Drugs (NSAID) Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Non-steroidal Anti-inflammatory Drugs (NSAID)
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Non-steroidal Anti-inflammatory Drugs (NSAID) by Different Types from 2016 to 2027
-
Table Consumption Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Salicylates
-
Figure Market Size and Growth Rate of Propionic acid derivatives
-
Figure Market Size and Growth Rate of Acetic acid derivatives
-
Figure Market Size and Growth Rate of Enolic acid (Oxicam) derivatives
-
Figure Market Size and Growth Rate of Anthranilic acid derivatives (Fenamates)
-
Figure Market Size and Growth Rate of Selective COX-2 inhibitors (Coxibs)
-
Figure Market Size and Growth Rate of Sulfonanilides
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Non-steroidal Anti-inflammatory Drugs (NSAID) by Different End-Users from 2016 to 2027
-
Table Consumption Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Human
-
Figure Market Size and Growth Rate of Animals
-
Figure Market Size and Growth Rate of Others
-
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Production by Regions
-
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Production Share by Regions
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Production Share by Regions in 2016
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Production Share by Regions in 2021
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Production Share by Regions in 2027
-
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption by Regions
-
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Regions
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Regions in 2016
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Regions in 2021
-
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Regions in 2027
-
Table West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption by Types from 2016 to 2027
-
Table West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types from 2016 to 2027
-
Figure West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types in 2016
-
Figure West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types in 2021
-
Figure West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types in 2027
-
Table West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption by End-Users from 2016 to 2027
-
Table West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users in 2016
-
Figure West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users in 2021
-
Figure West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users in 2027
-
Table South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption by Types from 2016 to 2027
-
Table South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types from 2016 to 2027
-
Figure South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types in 2016
-
Figure South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types in 2021
-
Figure South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types in 2027
-
Table South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption by End-Users from 2016 to 2027
-
Table South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users in 2016
-
Figure South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users in 2021
-
Figure South USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users in 2027
-
Table Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption by Types from 2016 to 2027
-
Table Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types in 2016
-
Figure Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types in 2021
-
Figure Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types in 2027
-
Table Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users in 2016
-
Figure Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users in 2021
-
Figure Middle West USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users in 2027
-
Table Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption by Types from 2016 to 2027
-
Table Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types in 2016
-
Figure Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types in 2021
-
Figure Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by Types in 2027
-
Table Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users in 2016
-
Figure Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users in 2021
-
Figure Northeast USA Non-steroidal Anti-inflammatory Drugs (NSAID) Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Generic
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Generic
-
Figure Sales and Growth Rate Analysis of Generic
-
Figure Revenue and Market Share Analysis of Generic
-
Table Product and Service Introduction of Generic
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Merial
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merial
-
Figure Sales and Growth Rate Analysis of Merial
-
Figure Revenue and Market Share Analysis of Merial
-
Table Product and Service Introduction of Merial
-
Table Company Profile and Development Status of Zoetis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zoetis
-
Figure Sales and Growth Rate Analysis of Zoetis
-
Figure Revenue and Market Share Analysis of Zoetis
-
Table Product and Service Introduction of Zoetis
-
Table Company Profile and Development Status of Elanco
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Elanco
-
Figure Sales and Growth Rate Analysis of Elanco
-
Figure Revenue and Market Share Analysis of Elanco
-
Table Product and Service Introduction of Elanco
-
Table Company Profile and Development Status of St Joseph
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of St Joseph
-
Figure Sales and Growth Rate Analysis of St Joseph
-
Figure Revenue and Market Share Analysis of St Joseph
-
Table Product and Service Introduction of St Joseph
-
Table Company Profile and Development Status of Boehringer Ingelheim
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
-
Table Product and Service Introduction of Boehringer Ingelheim
-
Table Company Profile and Development Status of Ecotrin
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ecotrin
-
Figure Sales and Growth Rate Analysis of Ecotrin
-
Figure Revenue and Market Share Analysis of Ecotrin
-
Table Product and Service Introduction of Ecotrin
-
Table Company Profile and Development Status of Merck Animal Health
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Animal Health
-
Figure Sales and Growth Rate Analysis of Merck Animal Health
-
Figure Revenue and Market Share Analysis of Merck Animal Health
-
Table Product and Service Introduction of Merck Animal Health
-